Current studies have shown that the expression level of PD-L1 in tumor tissue could be used to predict the efficacy of anti-PD-1 treatment (27); not only in patients with high expression of PD-L1 will it be effective, but also in patients with low expression of PD-L1. The gene discussed is CD274; the disease is neoplasm.